Additionally, the role of HOTAIR in the modulation of drug resistance mechanisms has been extensively described for several solid tumors [39–41], and since lncRNAs are molecules with high stability in biological fluids the detection of HOTAIR in the blood of CRC patients could represent an useful prognostic tool also for the prediction and monitoring of therapeutic response. This evidence concerns the gene HOTAIR and colorectal carcinoma.